These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33554324)

  • 1. Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic Review.
    Chhibber A; Watanabe AH; Chaisai C; Veettil SK; Chaiyakunapruk N
    Pharmacoeconomics; 2021 Apr; 39(4):399-420. PubMed ID: 33554324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.
    Le HH; Hodgkins P; Postma MJ; Kahle J; Sikirica V; Setyawan J; Erder MH; Doshi JA
    Eur Child Adolesc Psychiatry; 2014 Jul; 23(7):587-98. PubMed ID: 24166532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Cloutier M; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Guerin A; Lefebvre P
    J Med Econ; 2022; 25(1):193-205. PubMed ID: 35068300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
    Doshi JA; Hodgkins P; Kahle J; Sikirica V; Cangelosi MJ; Setyawan J; Erder MH; Neumann PJ
    J Am Acad Child Adolesc Psychiatry; 2012 Oct; 51(10):990-1002.e2. PubMed ID: 23021476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
    Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
    Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010.
    Erskine HE; Ferrari AJ; Nelson P; Polanczyk GV; Flaxman AD; Vos T; Whiteford HA; Scott JG
    J Child Psychol Psychiatry; 2013 Dec; 54(12):1263-74. PubMed ID: 24117530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.
    Schein J; Adler LA; Childress A; Gagnon-Sanschagrin P; Davidson M; Kinkead F; Cloutier M; Guérin A; Lefebvre P
    J Manag Care Spec Pharm; 2022 Feb; 28(2):168-179. PubMed ID: 34806909
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic Burden and Disability-Adjusted Life Years (DALYs) of Attention Deficit/Hyperactivity Disorder.
    Hong M; Park B; Lee SM; Bahn GH; Kim MJ; Park S; Oh IH; Park H
    J Atten Disord; 2020 Apr; 24(6):823-829. PubMed ID: 31364445
    [No Abstract]   [Full Text] [Related]  

  • 9. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    J Pediatr Psychol; 2007 Jul; 32(6):711-27. PubMed ID: 17556402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE; Foster EM; Robb JA
    Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden associated with stillbirth: A systematic review.
    Veettil SK; Kategeaw W; Hejazi A; Workalemahu T; Rothwell E; Silver RM; Chaiyakunapruk N
    Birth; 2023 Jun; 50(2):300-309. PubMed ID: 36774590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social and Economic Costs of Attention-Deficit/Hyperactivity Disorder Across the Lifespan.
    Sciberras E; Streatfeild J; Ceccato T; Pezzullo L; Scott JG; Middeldorp CM; Hutchins P; Paterson R; Bellgrove MA; Coghill D
    J Atten Disord; 2022 Jan; 26(1):72-87. PubMed ID: 33047627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.
    Thomas R; Sanders S; Doust J; Beller E; Glasziou P
    Pediatrics; 2015 Apr; 135(4):e994-1001. PubMed ID: 25733754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
    Seuring T; Archangelidi O; Suhrcke M
    Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of adult attention deficit hyperactivity disorder: A sibling comparison cost analysis.
    Daley D; Jacobsen RH; Lange AM; Sørensen A; Walldorf J
    Eur Psychiatry; 2019 Sep; 61():41-48. PubMed ID: 31288209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family Burden of Raising a Child with ADHD.
    Zhao X; Page TF; Altszuler AR; Pelham WE; Kipp H; Gnagy EM; Coxe S; Schatz NK; Merrill BM; Macphee FL; Pelham WE
    J Abnorm Child Psychol; 2019 Aug; 47(8):1327-1338. PubMed ID: 30796648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.